• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    68 Biggest Movers From Yesterday

    3/16/22 5:24:45 AM ET
    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Farming/Seeds/Milling
    Consumer Staples
    Industrial Specialties
    Health Care
    Get the next $AGFY alert in real time by email

    Gainers

    • Sonim Technologies, Inc. (NASDAQ:SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
    • Incannex Healthcare Limited (NASDAQ:IXHL) shares climbed 55% to close at $35.50 on Tuesday after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of data from its Phase 2 trial of a cannabinoid combination product, IHL-42X, for obstructive sleep apnoea (OSA).
    • Jaguar Health, Inc. (NASDAQ:JAGX) gained 44.5% to settle at $0.5453. Jaguar Health recently posted FY21 sales of $15.719 million.
    • RLX Technology Inc. (NASDAQ:RLX) shares climbed 40.2% to close at $1.71. RLX Technology, last week, reported Q4 earnings results.
    • CooTek (Cayman) Inc. (NYSE:CTK) shares rose 36.9% to close at $0.27 after reporting Q4 results.
    • Hour Loop Inc (NASDAQ:HOUR) gained 31.3% to settle at $3.99.
    • Sonendo Inc (NASDAQ:SONX) gained 30.8% to close at $4.45.
    • Rapid Micro Biosystems Inc (NASDAQ:RPID) gained 26.2% to settle at $7.57.
    • Kaival Brands Innovations Group, Inc (NASDAQ:KAVL) gained 25.9% to settle at $1.75.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) surged 25.4% to close at $3.21. JP Morgan, on Monday, downgraded the stock from Neutral to Underweight and announced a $3.5 price target.
    • Revelation Biosciences Inc (NASDAQ:REVB) gained 22.6% to close at $1.25 after the company announced the completion of enrollment and dosing in Phase 2b viral challenge study to evaluate the efficacy of intranasal REVTx-99 for the preventive treatment of H3N2 influenza.
    • New Oriental Education & Tech Grp (NYSE:EDU) gained 22.6% to settle at $1.06.
    • TherapeuticsMD Inc (NASDAQ:TXMD) gained 22.2% to close at $0.33.
    • Palisade Bio Inc (NASDAQ:PALI) climbed 22% to close at $1.18.
    • Janone Inc (NASDAQ:JAN) gained 21.9% to settle at $3.39.
    • Lion Group Holding Ltd – ADR (NASDAQ:LGHL) gained 21.4% to close at $1.05.
    • DocGo Inc (NASDAQ:DCGO) gained 21.1% to settle at $7.46. The company recently posted upbeat quarterly sales.
    • Sunworks Inc (NASDAQ:SUNW) climbed 20.6% to close at $3.04. Sunworks, last week, reported worse-than-expected Q4 adjusted EPS results.
    • Summer Infant, Inc. (NASDAQ:SUMR) gained 20.6% to settle at $8.50.
    • Shift Technologies Inc (NASDAQ:SFT) climbed 20.6% to close at $1.93 following quarterly results.
    • Allied Healthcare Products Inc (NASDAQ:AHPI) gained 20.5% to settle at $3.35.
    • Butterfly Network, Inc. (NYSE:BFLY) gained 20.3% to close at $4.50. FUJIFILM Sonosite recently filed patent infringement lawsuit against Butterfly Network.
    • Meta Materials Inc (NASDAQ:MMAT) climbed 19.9% to settle at $1.69.
    • Clearside Biomedical, Inc. (NASDAQ:CLSD) gained 19.7% to settle at $2.49.
    • Hall of Fame Resort & Entertainment Co (NASDAQ:HOFV) climbed 18.9% to close at $0.96.
    • Cerberus Cyber Sentinel Corp (NASDAQ:CISO) gained 18.4% to close at $5.19.
    • Modiv Inc (NYSE:MDV) gained 18.4% to settle at $20.71, possibly amid continued post-IPO volatility.
    • Qudian Inc – ADR (NYSE:QD) gained 18.4% to close at $0.75.
    • Procept Biorobotics Corp (NASDAQ:PRCT) climbed 18.4% to settle at $29.30. PROCEPT BioRobotics recently posted a Q4 loss of $0.42 per share.
    • Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) climbed 17.7% to close at $15.76. The state-owned operator of Beijing’s railway is weighing an offer for Hollysys Automation, Bloomberg reported.
    • CIRCOR International, Inc. (NYSE:CIR) gained 17.3% to close at $27.63.
    • Big Lots, Inc. (NYSE:BIG) gained 15.4% to settle at $36.93 after Mill Road Capital in a 13D filing said it believes a sale process could maximize value for shareholders.
    • Tencent Music Entertainment Group (NYSE:TME) surged 14.7% to settle at $3.58.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) gained 14.3% to close at $3.27. Sunshine Biopharma announced closing of $8.0 million private placement priced at-the-market.
    • Fossil Group, Inc. (NASDAQ:FOSL) climbed 13.6% to close at $9.17. Fossil Group, last week, reported Q4 earnings results.
    • Cano Health, Inc. (NYSE:CANO) gained 13.6% to settle at $6.03 following Q4 results.
    • Co-Diagnostics, Inc. (NASDAQ:CODX) rose 13.1% to close at $5.69. Co-Diagnostics reported authorization of $30 million share repurchase program.
    • Peloton Interactive, Inc. (NASDAQ:PTON) jumped 11.9% to close at $22.61. Bernstein initiated coverage on Peloton Interactive with an Outperform rating and announced a price target of $40.
    • Wejo Group Limited (NASDAQ:WEJO) gained 10.5% to close at $3.70.
    • Hycroft Mining Holding Corporation (NASDAQ:HYMC) shares gained 9.4% to settle at $1.52 after dipping 26% on Monday.
    • AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) rose 8.5% to close at $4.98. AVEO Pharmaceuticals, on Monday, posted a Q4 loss of $0.21 per share.
    • Wayfair Inc (NYSE:W) gained 7.6% to settle at $112.80.
    • AerSale Corporation (NASDAQ:ASLE) shares gained 6.1% to close at $15.22 after the company reported better-than-expected Q4 adjusted EPS and sales results.

     

    Losers

    • Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) shares tumbled 43.1% to close at $1.70 on Tuesday after the company reported Q4 results and issued weak FY22 sales outlook. Stifel downgraded Evolv Technologies from Buy to Hold and lowered the price target from $10 to $2.
    • Cepton, Inc. (NASDAQ:CPTN) dipped 28.8% to close at $4.28.
    • Four Seasons Education (Cayman) Inc. (NYSE:FEDU) dropped 26.4% to close at $0.3754
    • Better Therapeutics, Inc. (NASDAQ:BTTX) fell 23% to close at $3.12. Better Therapeutics said data from its pivotal trial of BT-001, an investigational PDT platform that is designed to use digitally delivered nCBT to treat type 2 diabetes, demonstrated clinically meaningful and statistically significant results in improving glycemic control by reducing A1c 0.4% versus the control group receiving standard of care.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) dropped 20.1% to close at $0.5316.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) dipped 19.8% to settle at $4.55.
    • Coupa Software Incorporated (NASDAQ:COUP) shares fell 19.2% to close at $72.55 after the company reported Q4 results and issued Q1 forecast.
    • Taoping Inc. (NASDAQ:TAOP) fell 19.2% to close at $1.14.
    • ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) fell 18.7% to settle at $29.01 after the company reported downbeat Q4 earnings and issued weak FY22 sales forecast.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) dropped 18.3% to close at $2.23. Red Cat, on Monday, announced its subsidiary Teal Drones has been selected by the Department of Defense's Defense Innovation Unit and U.S. Army to compete in the Short Range Reconnaissance Tranche 2 Program of Record.
    • China Natural Resources, Inc. (NASDAQ:CHNR) fell 17.9% to close at $0.87.
    • Bon Natural Life Limited (NASDAQ:BON) dropped 17.4% to close at $2.95. Bon Natural Life recently reported FY21 earnings results.
    • Save Foods, Inc. (NASDAQ:SVFD) dipped 17.3% to close at $5.47.
    • iPower Inc. (NASDAQ:IPW) dropped 16.7% to settle at $1.35.
    • Precision BioSciences, Inc. (NASDAQ:DTIL) fell 16.4% to close at $2.96 following FY21 results.
    • Avinger, Inc (NASDAQ:AVGR) fell 15.8% to close at $3.03.
    • Natera, Inc. (NASDAQ:NTRA) dropped 15.5% to close at $30.32.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) fell 14.4% to close at $0.5524.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) fell 13.6% to $2.9699.
    • Mammoth Energy Services, Inc. (NASDAQ:TUSK) dropped 11.9% to close at $1.78.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) shares fell 11.7% to settle at $21.00. Verve Therapeutics, on Monday, posted Q4 loss of $0.65 per share.
    • Agrify Corporation (NASDAQ:AGFY) fell 10.1% to close at $4.62. Agrify recently entered into a debt financing agreement for up to $135 million in a senior secured note facility with an institutional lender.
    • ION Geophysical Corporation (NYSE:IO) fell 9.3% to close at $0.9160.
    • Houston American Energy Corp. (NASDAQ:HUSA) fell 8% to close at $5.75.
    • Prelude Therapeutics Incorporated (NASDAQ:PRLD) fell 7.7% to close at $7.15. B of A Securities downgraded Prelude Therapeutics from Buy to Neutral and lowered the price target from $50 to $10.
    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $AHPI
    $ANIP
    $ASLE

    CompanyDatePrice TargetRatingAnalyst
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Modiv Industrial Inc.
    $MDV
    2/4/2026$18.00Overweight
    Cantor Fitzgerald
    New Oriental Education & Technology Group Inc. Sponsored ADR r
    $EDU
    1/28/2026Hold → Buy
    HSBC Securities
    Palisade Bio Inc.
    $PALI
    1/9/2026$7.00Buy
    B. Riley Securities
    Natera Inc.
    $NTRA
    1/7/2026$300.00Buy
    Citigroup
    Wayfair Inc.
    $W
    1/7/2026$123.00Equal Weight → Overweight
    Barclays
    Palisade Bio Inc.
    $PALI
    12/29/2025$25.00Overweight
    Piper Sandler
    PROCEPT BioRobotics Corporation
    $PRCT
    12/12/2025$62.00Buy
    UBS
    More analyst ratings

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    SEC Filings

    View All

    SEC Form PRE 14A filed by Revelation Biosciences Inc.

    PRE 14A - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

    2/6/26 4:32:19 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wayfair Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Wayfair Inc. (0001616707) (Filer)

    2/6/26 4:15:11 PM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Hycroft Mining Holding Corporation filed SEC Form 8-K: Leadership Update, Shareholder Director Nominations, Other Events

    8-K - HYCROFT MINING HOLDING CORP (0001718405) (Filer)

    2/6/26 9:00:41 AM ET
    $HYMC
    Precious Metals
    Basic Materials

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Peloton with a new price target

    Telsey Advisory Group reiterated coverage of Peloton with a rating of Market Perform and set a new price target of $6.00 from $8.00 previously

    2/6/26 6:46:09 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on Modiv with a new price target

    Cantor Fitzgerald initiated coverage of Modiv with a rating of Overweight and set a new price target of $18.00

    2/4/26 8:29:58 AM ET
    $MDV
    Real Estate Investment Trusts
    Real Estate

    New Oriental Education & Technology upgraded by HSBC Securities

    HSBC Securities upgraded New Oriental Education & Technology from Hold to Buy

    1/28/26 3:01:34 PM ET
    $EDU
    Other Consumer Services
    Real Estate

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Longitude Capital Partners Ii, Llc sold $190,091 worth of shares (49,000 units at $3.88) (SEC Form 4)

    4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)

    2/6/26 4:26:26 PM ET
    $RPID
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 5 filed by Evans Allan Thomas

    5 - Red Cat Holdings, Inc. (0000748268) (Issuer)

    2/5/26 9:13:12 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Director Roper Jess covered exercise/tax liability with 1,591 shares, decreasing direct ownership by 11% to 12,828 units (SEC Form 4)

    4 - REVELATION BIOSCIENCES, INC. (0001810560) (Issuer)

    2/5/26 5:31:20 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BIJUVA issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug BIJUVA (SUPPL-6) with active ingredient ESTRADIOL; PROGESTERONE has changed to 'Approval' on 12/28/2021. Application Category: NDA, Application Number: 210132, Application Classification: Efficacy

    12/29/21 7:23:57 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for IMVEXXY issued to THERAPEUTICSMD INC

    Submission status for THERAPEUTICSMD INC's drug IMVEXXY (SUPPL-2) with active ingredient ESTRADIOL has changed to 'Approval' on 11/16/2021. Application Category: NDA, Application Number: 208564, Application Classification: Labeling

    11/17/21 4:38:32 AM ET
    $TXMD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XIPERE issued to CLEARSIDE BIOMEDICAL, INC

    Submission status for CLEARSIDE BIOMEDICAL, INC's drug XIPERE (ORIG-1) with active ingredient TRIAMCINOLONE ACETONIDE has changed to 'Approval' on 10/22/2021. Application Category: NDA, Application Number: 211950, Application Classification: Type 3 - New Dosage Form

    10/25/21 2:22:37 PM ET
    $CLSD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Sprott Eric bought $9,198,000 worth of shares (200,000 units at $45.99) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    1/30/26 8:35:50 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Large owner Sprott Eric bought $4,996,000 worth of shares (100,000 units at $49.96) (SEC Form 4)

    4 - HYCROFT MINING HOLDING CORP (0001718405) (Issuer)

    1/27/26 9:16:28 PM ET
    $HYMC
    Precious Metals
    Basic Materials

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes

    Large prospective study to evaluate a non-invasive prenatal screening test Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study designed to evaluate the company's non-invasive prenatal screening test for early risk assessment of preeclampsia and other serious pregnancy complications. Preeclampsia affects approximately 5-8% of pregnancies and remains a leading cause of maternal and neonatal morbidity.1 While clinical guidelines recommend low-dose aspirin for patients with established risk factors for preeclampsia2, current risk assessment relies primarily on clinical characteristic

    2/6/26 6:00:00 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Mammoth Announces Fourth-Quarter and Full-Year 2025 Conference Call

    OKLAHOMA CITY, Feb. 5, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") will host a conference call on Friday, March 6, 2026, to discuss the Company's results for the fourth quarter and full year ended December 31, 2025. The conference call will begin at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). Prior to the call, the Company will issue a press release announcing the results, which will also be available in the Investor Relations section of the Mammoth website. The call will be webcast live and can be accessed through the C

    2/5/26 4:30:00 PM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Affirm and Wayfair expand partnership to the UK and Canada

    Affirm (NASDAQ:AFRM) today announced the expansion of its partnership with Wayfair (NYSE:W), bringing its honest financial products to shoppers in the UK and Canada. Whether shopping for a new dining table or the perfect sofa, approved shoppers in the UK and Canada can now split their purchases with Affirm. The experience is straightforward: customers receive a quick, real-time approval decision and can choose the payment plan that fits their needs. Affirm never charges late fees or hidden fees, and there is no compounding interest. Customers only pay what they agree to. Today's announcement builds on the companies' recently expanded partnership, which brought Affirm to Wayfair's onli

    2/5/26 4:15:00 PM ET
    $AFRM
    $W
    Finance: Consumer Services
    Finance
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Leadership Updates

    Live Leadership Updates

    View All

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

    MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Advisory Board ("CAB"): Murray B. Stein, MD, MPH; Andrew Cutler, MD; and Amir Kalali, MD. The CAB was formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The addition of Drs. Stein, Cutler, and Kalali further strengthens the Board's expertise across psychiatry, neurobiology, psychopharmacology, an

    1/29/26 8:00:00 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Financials

    Live finance-specific insights

    View All

    Mammoth Announces Fourth-Quarter and Full-Year 2025 Conference Call

    OKLAHOMA CITY, Feb. 5, 2026 /PRNewswire/ -- Mammoth Energy Services, Inc. (NASDAQ:TUSK) ("Mammoth" or the "Company") will host a conference call on Friday, March 6, 2026, to discuss the Company's results for the fourth quarter and full year ended December 31, 2025. The conference call will begin at 11:00 a.m. Eastern Time (10:00 a.m. Central Time). Prior to the call, the Company will issue a press release announcing the results, which will also be available in the Investor Relations section of the Mammoth website. The call will be webcast live and can be accessed through the C

    2/5/26 4:30:00 PM ET
    $TUSK
    Oilfield Services/Equipment
    Energy

    Peloton Announces Q2 FY2026 Financial Results

    Delivered Year-over-Year Improvement in Profitability While Investing in Ambitious Innovation Agenda Raises Full Year FY2026 Adjusted EBITDA Guidance to $450 - $500 million* NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. today reported financial results for the quarter ended December 31, 2025. Q2 FY2026 Financial Highlights Ending Paid Connected Fitness Subscriptions were 2.661 million, a decrease of 214,000 or 7% year-over-year and 6,000 above the midpoint of our guidance range. We observed better-than-expected Average Net Monthly Paid Connected Fitness Subscription Churn following Membership price increases announced on October 1, which was partially offset by l

    2/5/26 7:00:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Butterfly Network to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on February 26 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor

    2/3/26 8:01:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $AGFY
    $AHPI
    $ANIP
    $ASLE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology